Hospital-acquired Pressure Ulcers (HAPU) affect more than 2.5 million patients in the U.S. and results in significant patient harm; including pain, expensive treatments, increased length of stay and premature mortality.
While pressure ulcers are largely preventable, incidence rates continue to rise. The cost of treating a single pressure ulcer can be as high as $70,000, and the total cost for treatment in the U.S. is estimated at $11 billion annually (Reddy, Gill & Rochon, 2006. Risks for the development of pressure ulcers include advanced age, immobility, incontinence, inadequate nutrition and hydration, neuro-sensory deficiency, device-related skin pressure, multiple co-morbidities and circulatory abnormalities (IHI, 2011; Lyder & Ayello, 2008). Interventions to prevent or quickly treat pressure ulcers can reduce the costs of HAPU care and significantly improve quality of life for those affected.
From 2015 to 2016, the AHA/HRET HEN 2.0 prevented an estimated 1,122 HAPUs with an estimated cost savings of over $19 million.
20 percent reduction in Hospital-acquired Pressure Ulcers by 2019.Partnership for Patients (PfP) Goal